Investing.com-- Oil prices fell Thursday, retreating after the previous session's strong gains, after the release of disappointing U.S. growth data. At 10:10 ET (14:10 GMT), Brent Oil Futures ...

EAG Bioenergy (EAGB), which is backed by Vesper Infrastructure and OrbeNovo Capital, has acquired a new biogas plant, GTG Biogas (Toomebridge) Limited (GTG). This acquisition of a new, fully operating ...

New Delhi: The Central Pollution Control Board (CPCB) has issued fresh directions to all State Pollution Control Boards (SPCBs) and Pollution Control Committees (PCCs) to adopt a revised ...

NEW YORK, March 27 (Reuters) - U.S. President Donald Trump's administration has asked oil and biofuels producers to hash out a deal on the next phase of the nation's biofuels policy to avoid the ...

Code to create combinatorial media on the BioMek NXP platform with descriptions about how to use in an automated DBTL cycle.

The consumer and industrial adoption of solar, wind, hydro, and bio-energy, alongside growing investments in the brands' stocks in these industries, is reshaping the country’s energy landscape.

1546 GMT – Oil prices extend gains in afternoon trade, buoyed by U.S. stockpile draws and U.S. pressure on Iran and Venezuela. Brent crude is up 1.2% to $73.27 a barrel, while WTI rises 1.4% to ...

Crude inventories fell by 3.3 million barrels to 433.6 million barrels in the week ended March 21, the EIA said, a deeper draw than the 956,000 barrels that analysts had expected in a Reuters poll.

Indiana’s organic waste management landscape is ready to transform with the groundbreaking of the Kingsbury Bioenergy Complex. The project, privately funded and operated by a leading waste-to-value ...

The American Petroleum Institute (API) estimated that crude oil inventories in the United States fell by 4.6 million barrels for the week ending March 21. Analysts had expected a dip of 2.5 ...

This is in contrast to the policy of the previous government, which had initiated a slow phase-out of bioenergy.

The flur­ry of im­munol­o­gy biotech launch­es con­tin­ues. Boston-based Hill­star Bio on Tues­day be­came the lat­est im­munol­o­gy start­up launch, un­veil­ing a $67 mil­lion ...